Primary Site >> Colorectal Cancer
Gene >> UGT2B7
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. PMID: 10220484 |
Ref: Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. PMID: 10901286 |
Ref: Genetic polymorphism in UDP-glucuronosyltransferase 2B7 and colorectal cancer risk. PMID: 19408577 |
Ref: Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. PMID: 25677447 |
Ref: Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor. PMID: 28418861 Ref: Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study. PMID: 29282011 |
Ref: Drug-drug interaction potential of antitumor acridine agent C-1748: The substrate of UDP-glucuronosyltransferases 2B7, 2B17 and the inhibitor of 1A9 and 2B7. PMID: 30107347 |